{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:06:30Z","timestamp":1767888390866,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006800","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T00:00:00Z","timestamp":1329264000000}}],"reference-count":97,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006800.pub2","type":"journal-article","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T19:54:46Z","timestamp":1328903686000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Pentoxifylline for diabetic kidney disease"],"prefix":"10.1002","volume":"2013","author":[{"given":"Dan","family":"Shan","sequence":"first","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Geriatrics; No. 37 Guo Xue Xiang Street Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Mei","family":"Wu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Geriatrics; No. 37 Guo Xue Xiang Street Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi Yuan","family":"Yuan","sequence":"additional","affiliation":[{"name":"No.5 People's Hospital of Chengdu; Intensive Care Department; Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Geriatrics; No. 37 Guo Xue Xiang Street Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong Le","family":"Zhou","sequence":"additional","affiliation":[{"name":"Xi'an No.4 Hospital, Xi'an JiaoTong University; Department of Ophthalmology; No.21, Jie Fang Road Xi'an Shaanxi China 710004"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan J","family":"Liu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Chinese Cochrane Centre, Chinese Evidence-Based Medicine Centre; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,2,15]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD006800.pub2-BIB0001|cit1","first-page":"c73","article-title":"Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus","volume":"99","author":"Aminorroaya","year":"2005","journal-title":"Nephron"},{"issue":"12","key":"10.1002\/14651858.CD006800.pub2-BIB0002|cit2","first-page":"1365","article-title":"Clinical observation of pentoxifylline in reducing proteinuria in patients with diabetic nephropathy","volume":"19","author":"Gan","year":"2003","journal-title":"Shiyong Yixue Zazhi [Journal of Practical Medicine]"},{"issue":"2","key":"10.1002\/14651858.CD006800.pub2-BIB0003|cit3","first-page":"116","article-title":"Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients","volume":"43","author":"Guerrero-Romero","year":"1995","journal-title":"Clinical Nephrology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006800.pub2-BIB0004|cit4","first-page":"25","article-title":"Combination of pentoxifylline with angiotensin converting enzyme inhibitors (ACEi) produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients [abstract]","volume":"17","author":"Harmankaya","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD006800.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1081\/JDI-120021159","article-title":"Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients","volume":"25","author":"Harmankaya","year":"2003","journal-title":"Renal Failure"},{"issue":"20","key":"10.1002\/14651858.CD006800.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.medcli.2008.05.024","article-title":"Effect of pentoxifylline on the evolution of diabetic nephropathy","volume":"132","author":"Leyva-Jimenez","year":"2009","journal-title":"Medicina Clinica"},{"issue":"6","key":"10.1002\/14651858.CD006800.pub2-BIB0009|cit7","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2337\/diacare.22.6.1006","article-title":"Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy","volume":"22","author":"Navarro","year":"1999","journal-title":"Diabetes Care"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD006800.pub2-BIB0007|cit8","first-page":"120A","article-title":"Pentoxifylline (PTF) reduces proteinuria and tumor necrosis factor-alpha (TNFa) in diabetic patients with advanced renal failure [abstract]","volume":"9","author":"Navarro","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD006800.pub2-BIB0008|cit9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(99)70182-4","article-title":"Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration","volume":"33","author":"Navarro","year":"1999","journal-title":"American Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD006800.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0272-6386(03)00651-6","article-title":"Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study","volume":"42","author":"Navarro","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD006800.pub2-BIB0011|cit11","first-page":"58A","article-title":"Additive antiproteinuric effect of pentoxifylline in diabetic nephropathy [abstract]","volume":"16","author":"Navarro","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD006800.pub2-BIB0012|cit12","first-page":"v239","article-title":"Additive antiproteinuric effect of pentoxifylline in type 2 diabetic patients under angiotensin II receptor blockade [abstract]","volume":"20","author":"Navarro","year":"2005","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD006800.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1681\/ASN.2005010001","article-title":"Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial","volume":"16","author":"Navarro","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"20","key":"10.1002\/14651858.CD006800.pub2-BIB0014|cit14","first-page":"1185","article-title":"Effect of pentoxifylline in the treatment of early diabetic nephropathy","volume":"18","author":"Pang","year":"2003","journal-title":"Linchuang Huicui [Clinical Focus]"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006800.pub2-BIB0015|cit15","first-page":"104","article-title":"Effects of pentoxifylline in diabetic nephropathy [abstract]","volume":"18","author":"Pantoja","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD006800.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5414\/CNP64091","article-title":"Pentoxifylline is as effective as captopril in the reduction of microalbuminuria in non-hypertensive type 2 diabetic patients - a randomized, equivalent trial","volume":"64","author":"Rodriguez-Moran","year":"2005","journal-title":"Clinical Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD006800.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5414\/CNP66003","article-title":"Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria: a double-blind, placebo-controlled randomized trial","volume":"66","author":"Rodriguez-Moran","year":"2006","journal-title":"Clinical Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD006800.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02624677","article-title":"Pentoxifylline, albumin excretion rate and proteinuria in type I and type II diabetic patients with microproteinuria. Results of a short-term randomized study","volume":"23","author":"Solerte","year":"1986","journal-title":"Acta Diabetologica Latina"},{"issue":"3","key":"10.1002\/14651858.CD006800.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF02732042","article-title":"Pentoxifylline, total urinary protein excretion rate and arterial blood pressure in long-term insulin-dependent diabetic patients with overt nephropathy","volume":"24","author":"Solerte","year":"1987","journal-title":"Acta Diabetologica Latina"},{"issue":"10","key":"10.1002\/14651858.CD006800.pub2-BIB0020|cit20","first-page":"460","article-title":"Effect of pentoxifylline on diabetic nephropathy","volume":"11","author":"Sui","year":"1999","journal-title":"Shanghai Yufang Yixue [Shanghai Journal of Preventive Medicine]"},{"issue":"4","key":"10.1002\/14651858.CD006800.pub2-BIB0021|cit21","first-page":"229","article-title":"The effect of pentoxifylline in the treatment of early diabetic nephropathy","volume":"27","author":"Zang","year":"1999","journal-title":"TianJin Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006800.pub2-BIB0022|cit22","first-page":"213","article-title":"Effect of pentoxifylline in the treatment of early diabetic nephropathy in the elderly","volume":"8","author":"Zhang","year":"2001","journal-title":"Zhongguo ZhongXiyi Jiehe Jijiu Zazhi [Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care]"},{"issue":"7","key":"10.1002\/14651858.CD006800.pub2-BIB0023|cit23","first-page":"57","article-title":"Pentoxifylline in the treatment of diabetic nephropathy","volume":"4","author":"Cen","year":"2005","journal-title":"Chinese Journal of Current Practical Medicine"},{"key":"10.1002\/14651858.CD006800.pub2-BIB0024|cit24","unstructured":"Chua AT Yu RMH Effect of pentoxifylline on the course of diabetic nephropathy [abstract] 6th Asian Pacific Congress of Nephrology; 1995 Dec 5-9; Hong Kong 1995 111"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006800.pub2-BIB0025|cit25","first-page":"183","article-title":"Effects of pentoxifylline on the cytokines that may play a role in rejection and resistive index in renal transplant recipients [abstract]","volume":"20","author":"Demir","year":"2007","journal-title":"Transplant International"},{"issue":"12","key":"10.1002\/14651858.CD006800.pub2-BIB0026|cit26","first-page":"1144","article-title":"Pentoxifylline in the treatment of diabetic nephropathy","volume":"32","author":"Diao","year":"2003","journal-title":"Shanxi Yiyao Zazhi [Shanxi Medical Journal]"},{"issue":"4","key":"10.1002\/14651858.CD006800.pub2-BIB0027|cit27","first-page":"410","article-title":"Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker?","volume":"20","author":"Diskin","year":"2007","journal-title":"Journal of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD006800.pub2-BIB0028|cit28","first-page":"33","article-title":"Renal and retinal changes after treatment with ramipril and pentoxifylline in subjects with IDDM","volume":"30","author":"Garg","year":"1998","journal-title":"Annals of Ophthalmology-Glaucoma"},{"issue":"Abstracts Issue","key":"10.1002\/14651858.CD006800.pub2-BIB0029|cit29","first-page":"4A","article-title":"Pentoxifylline decreases C-reactive protein in hemodialysis: a randomized, double-blinded, controlled clinical trial [abstract]","volume":"19","author":"Gonzalez-Espinoza","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD006800.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00592-008-0064-5","article-title":"Effects of pentoxifylline and pentosan polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus","volume":"46","author":"Laczy","year":"2009","journal-title":"Acta Diabetologica"},{"issue":"Abstracts","key":"10.1002\/14651858.CD006800.pub2-BIB0031|cit31","first-page":"56A","article-title":"Add-on pentoxifylline attenuated residual proteinuria in patients of moderate to advanced chronic kidney disease receiving maximized losartan treatment [abstract]","volume":"17","author":"Lin","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD006800.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/j.ajkd.2008.05.012","article-title":"Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial","volume":"52","author":"Lin","year":"2008","journal-title":"American Journal of Kidney Diseases"},{"issue":"2-3","key":"10.1002\/14651858.CD006800.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.vph.2007.05.004","article-title":"Effect of Pentoxifylline on inflammatory burden, oxidative stress and platelet aggregability in hypertensive type 2 diabetes mellitus patients","volume":"47","author":"Maiti","year":"2007","journal-title":"Vascular Pharmacology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006800.pub2-BIB0034|cit34","first-page":"iv83","article-title":"Remarkable effects of pentoxifylline on microalbuminuria and serum CRP in diabetic patients [abstract]","volume":"21","author":"Mooraki","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD006800.pub2-BIB0035|cit35","first-page":"1493","article-title":"Effects of pentoxifylline on hemotologic status in anemic patients with advanced renal failure [abstract]","volume":"7","author":"Navarro","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD006800.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/003655999750016113","article-title":"Effects of pentoxifylline on the haematologic status in anaemic patients with advanced renal failure","volume":"33","author":"Navarro","year":"1999","journal-title":"Scandinavian Journal of Urology & Nephrology"},{"issue":"7-8","key":"10.1002\/14651858.CD006800.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1177\/106002809603000702","article-title":"Multiple-dose pharmacokinetics of pentoxifylline and its metabolites during renal insufficiency","volume":"30","author":"Paap","year":"1996","journal-title":"Annals of Pharmacotherapy"},{"issue":"4","key":"10.1002\/14651858.CD006800.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1053\/j.ajkd.2008.11.026","article-title":"Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial","volume":"53","author":"Perkins","year":"2009","journal-title":"American Journal of Kidney Diseases"},{"issue":"Abstracts Issue","key":"10.1002\/14651858.CD006800.pub2-BIB0039|cit39","first-page":"46A","article-title":"Pentoxifylline in patients with progressive chronic kidney disease: a pilot, double-blind, randomized, placebo-controlled trial [abstract]","volume":"19","author":"Perkins","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD006800.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","volume":"20","author":"American Diabetes Association","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD006800.pub2-BIB0041|cit41","first-page":"S79","article-title":"Nephropathy in diabetes","volume":"27 Suppl 1","author":"Molitch","year":"2004","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD006800.pub2-BIB0042|cit42","first-page":"c73","article-title":"Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus","volume":"99","author":"Aminorroaya","year":"2005","journal-title":"Nephron"},{"issue":"7","key":"10.1002\/14651858.CD006800.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.2337\/diacare.26.7.2150","article-title":"Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study","volume":"26","author":"Bruno","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1002\/14651858.CD006800.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ndt\/14.1.129","article-title":"Abysmal prognosis of patients with type 2 diabetes entering dialysis","volume":"14","author":"Chantrel","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD006800.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2337\/diacare.19.2.130","article-title":"Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy","volume":"19","author":"Chen","year":"1996","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD006800.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1523-1755.1999.00636.x","article-title":"Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis","volume":"56","author":"Chen","year":"1999","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD006800.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/ndt\/gfh127","article-title":"Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats","volume":"19","author":"Chen","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD006800.pub2-BIB0048|cit48","first-page":"A5","article-title":"Excerpts from the United States Renal Data System 2004 Annual Data Report: Atlas of end-stage renal disease in the United States","volume":"42","author":"Collins","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD006800.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.semnephrol.2007.01.002","article-title":"Albuminuria: a target for treatment of type 2 diabetic nephropathy","volume":"27","author":"Zeeuw","year":"2007","journal-title":"Seminars in Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD006800.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1681\/ASN.2006050445","article-title":"Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: Post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial","volume":"18","author":"Eijkelkamp","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD006800.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1046\/j.1523-1755.2000.00331.x","article-title":"Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study","volume":"58","author":"Festa","year":"2000","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD006800.pub2-BIB0052|cit52","first-page":"116","article-title":"Pentoxifylline reduces proteinuria in insulin-dependent and non insulin dependent diabetic patients","volume":"43","author":"Guerrero-Romero","year":"1995","journal-title":"Clinical Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD006800.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10753-009-9167-6","article-title":"Prolonged administration enhances the renoprotective effect of pentoxifylline via anti-inflammatory activity in streptozotocin-induced diabetic nephropathy","volume":"33","author":"Han","year":"2010","journal-title":"Inflammation"},{"issue":"7414","key":"10.1002\/14651858.CD006800.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006800.pub2-BIB0055|cit55","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"21","key":"10.1002\/14651858.CD006800.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200105243442106","article-title":"Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment","volume":"344","author":"Hrobjartsson","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"7048","key":"10.1002\/14651858.CD006800.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"36\u20139","DOI":"10.1136\/bmj.313.7048.36","article-title":"Trials to assess equivalence: the importance of rigorous methods","volume":"313","author":"Jones","year":"1996","journal-title":"BMJ"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD006800.pub2-BIB0058|cit58","first-page":"S1","article-title":"K\/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease","volume":"43","author":"Kidney Disease Outcomes Quality Initiative (K\/DOQI)","year":"2004","journal-title":"American Journal of Kidney Diseases"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD006800.pub2-BIB0059|cit59","first-page":"S12","article-title":"KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease","volume":"49","author":"Kidney Disease Outcomes Quality Initiative (K\/DOQI)","year":"2007","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD006800.pub2-BIB0060|cit60","unstructured":"Kjaergard LL Villumsen J Gluud C Quality of randomised clinical trials affects estimates of intervention efficacy Seventh International Cochrane Colloquium; 1999 Oct 5-9; Rome (Italy) 1999 57"},{"issue":"12","key":"10.1002\/14651858.CD006800.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1097\/01.ASN.0000034909.10994.8A","article-title":"Pentoxifylline attenuated the renal disease progression in rats with remnant kidney","volume":"13","author":"Lin","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD006800.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1053\/j.ajkd.2008.01.025","article-title":"The effect of pentoxifylline on proteinuria in diabetic kidney disease: A meta-analysis","volume":"52","author":"McCormick","year":"2008","journal-title":"American Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD006800.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ahj.2004.03.042","article-title":"Slowing the progression of diabetic nephropathy and its cardiovascular consequences","volume":"148","author":"McCullough","year":"2004","journal-title":"American Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD006800.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/ndt\/gfi163","article-title":"The unrecognized prevalence of chronic kidney disease in diabetes","volume":"21","author":"Middleton","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD006800.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.2337\/diab.46.2.S104","article-title":"How to protect the kidney in diabetic patients: with special reference to IDDM","volume":"46 Suppl 2","author":"Mogensen","year":"1997","journal-title":"Diabetes"},{"issue":"9128","key":"10.1002\/14651858.CD006800.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD006800.pub2-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007784","article-title":"HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis","author":"Navaneethan","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006800.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(99)70182-4","article-title":"Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration","volume":"33","author":"Navarro","year":"1999","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006800.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(03)00408-6","article-title":"Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus","volume":"42","author":"Navarro","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"issue":"5","key":"10.1002\/14651858.CD006800.pub2-BIB0070|cit70","first-page":"381","article-title":"Diabetic nephropathy: A matter of inflammation?","volume":"23","author":"Navarro","year":"2003","journal-title":"Nefrologia"},{"issue":"2","key":"10.1002\/14651858.CD006800.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0272-6386(03)00651-6","article-title":"Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study","volume":"42","author":"Navarro","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"issue":"7","key":"10.1002\/14651858.CD006800.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1681\/ASN.2005010001","article-title":"Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial","volume":"16","author":"Navaroo","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD006800.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1159\/000098004","article-title":"Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration","volume":"26","author":"Navarro","year":"2006","journal-title":"American Journal of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD006800.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1681\/ASN.2007091048","article-title":"The role of Inflammatory cytokines in diabetic nephropathy","volume":"19","author":"Navarro-Gonzalez","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD006800.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.hjh.0000217862.50735.dc","article-title":"Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study","volume":"24","author":"Olsen","year":"2006","journal-title":"Journal of Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD006800.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00125-008-1224-4","article-title":"High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study","volume":"52","author":"Rabbani","year":"2009","journal-title":"Diabetologia"},{"issue":"5","key":"10.1002\/14651858.CD006800.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0272-6386(99)70035-1","article-title":"End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions","volume":"34","author":"Ritz","year":"1999","journal-title":"American Journal of Kidney Diseases"},{"issue":"15","key":"10.1002\/14651858.CD006800.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM199910073411506","article-title":"Nephropathy in patients with type 2 diabetes mellitus","volume":"341","author":"Ritz","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006800.pub2-BIB0079|cit79","first-page":"481","article-title":"Diabetic nephropathy","volume":"17","author":"Ritz","year":"2006","journal-title":"Saudi Journal of Kidney Diseases & Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD006800.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/CS20080394","article-title":"Pathogenic perspectives for the role of inflammation in diabetic nephropathy","volume":"116","author":"Rivero","year":"2009","journal-title":"Clinical Science"},{"issue":"4","key":"10.1002\/14651858.CD006800.pub2-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002181.pub2","article-title":"Protein restriction for diabetic renal disease","author":"Robertson","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006800.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0895-4356(98)00149-8","article-title":"Are randomized control trial outcomes influenced by the inclusion of a placebo group?: A systematic review of nonsteroidal antiinflammatory drug trials for arthritis treatment","volume":"52","author":"Rochon","year":"1999","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD006800.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD006800.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1191\/096120301675275538","article-title":"Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFalpha monoclonal antibody and by pentoxifylline","volume":"10","author":"Segal","year":"2001","journal-title":"Lupus"},{"issue":"4","key":"10.1002\/14651858.CD006800.pub2-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006257","article-title":"Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease","author":"Strippoli","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD006800.pub2-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004136.pub2","article-title":"Antihypertensive agents for preventing diabetic kidney disease","author":"Strippoli","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006800.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.ki.5001515","article-title":"Simvastatin maintains steady patterns of GFR and improves AER and expression of slit diaphragm proteins in type II diabetes","volume":"70","author":"Tonolo","year":"2006","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD006800.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1159\/000187415","article-title":"Pentoxifylline in management of proteinuria in diabetic nephropathy","volume":"64","author":"Tripathy","year":"1993","journal-title":"Nephron"},{"issue":"20","key":"10.1002\/14651858.CD006800.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.1994.03510440069036","article-title":"The importance of placebo effects in pain treatment and research","volume":"271","author":"Turner","year":"1994","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006800.pub2-BIB0090|cit90","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States http:\/\/www.usrds.org\/atlas09.aspx"},{"key":"10.1002\/14651858.CD006800.pub2-BIB0091|cit91","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States http:\/\/www.usrds.org\/atlas.aspx"},{"issue":"10","key":"10.1002\/14651858.CD006800.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1080\/08860220802389342","article-title":"The effects of spironolactone on nephron function in patients with diabetic nephropathy","volume":"30","author":"Ustundag","year":"2008","journal-title":"Renal Failure"},{"issue":"14","key":"10.1002\/14651858.CD006800.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo response in studies of major depression: variable, substantial, and growing","volume":"287","author":"Walsh","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD006800.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","article-title":"Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy","volume":"34","author":"Ward","year":"1987","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD006800.pub2-BIB0095|cit95","unstructured":"World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications http:\/\/whqlibdoc.who.int\/hq\/1999\/WHO_NCD_NCS_99.2.pdf"},{"issue":"7644","key":"10.1002\/14651858.CD006800.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"issue":"2007","key":"10.1002\/14651858.CD006800.pub2-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006800","article-title":"Pentoxifylline for diabetic kidney disease","author":"Wu","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006800.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T08:17:51Z","timestamp":1739780271000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006800.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,2,15]]},"references-count":97,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006800.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,15]]}}}